![]() |
| |
39,834 $ | -2,01% | -0,8163 $ |
1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
Kurs | 38,40 $ | 37,85 $ | 28,10 $ | 28,30 $ | 11,45 $ | 3,43 $ |
Änderung | +3,76% | +5,27% | +41,80% | +40,80% | +247,99% | +1.061,66% |
06.01.14 | Frost & Sullivan Applaud AxoGen's Proprietary Process for Producing Decellularized Nerve Allografts | PR Newswire |
06.01.14 | Frost & Sullivan Applaud AxoGen's Proprietary Process for Producing Decellularized Nerve Allografts | PR Newswire |
09.10.12 | PDL BioPharma Completes Royalty Transaction with AxoGen | PR Newswire |
Aktienanzahl | 11,1 Mio. (Stand: 08.09.12) |
Marktkap. | 440,8 Mio. $ |
Keine Daten im genannten Zeitraum vorhanden |